Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J S Abrams

Showing results (21-30 of 121) with videos related to

Pageof 13
Sort By:
Diseases of the Colon and Rectum|March 1, 1979
The significance of a "positive" rectal examination in acute appendicitisJ C Bonello, J S Abrams
Oncology|January 1, 1992
Potential applications of high-dose megestrol acetate in breast cancerJ S Abrams, J Gutheil, J Aisner
Seminars in Oncology|December 1, 1990
Current status of high-dose progestins in breast cancerJ S Abrams, H Parnes, J Aisner
Cancer|August 1, 1994
New chemotherapeutic agents for breast cancerJ S Abrams, T D Moore, M Friedman
Oncology (Williston Park, N.Y.)|August 1, 1997
Clinical trials referral resourceB Cheson, J S Abrams, A P Nelson
Molecular Medicine (Cambridge, Mass.)|November 1, 1995
Administration of neutralizing antibodies to interleukin-6 (IL-6) reduces experimental autoimmune encephalomyelitis and is associated with elevated levels of IL-6 bioactivity in central nervous system and circulationK Gijbels, S Brocke, J S Abrams, et al.
Blood|April 1, 1991
Interleukin-5 is a human basophilopoietin: induction of histamine content and basophilic differentiation of HL-60 cells and of peripheral blood basophil-eosinophil progenitorsJ A Denburg, J E Silver, J S Abrams
The Journal of Trauma|July 1, 1976
Pulmonary function in patients with multiple trauma and associated severe head injuryJ S Abrams, R S Deane, J H Davis
Oncology (Williston Park, N.Y.)|December 1, 1993
Clinical trials referral resource. Metastatic breast cancerB D Cheson, P H Phillips, J S Abrams
Annals of Internal Medicine|October 1, 1996
High-dose chemotherapy for breast cancerW J Gradishar, M S Tallman, J S Abrams
Pageof 13

Showing results (21-30 of 121) with videos related to

Sort By:
Pageof 13
Diseases of the Colon and Rectum|March 1, 1979
The significance of a "positive" rectal examination in acute appendicitisJ C Bonello, J S Abrams
Oncology|January 1, 1992
Potential applications of high-dose megestrol acetate in breast cancerJ S Abrams, J Gutheil, J Aisner
Seminars in Oncology|December 1, 1990
Current status of high-dose progestins in breast cancerJ S Abrams, H Parnes, J Aisner
Cancer|August 1, 1994
New chemotherapeutic agents for breast cancerJ S Abrams, T D Moore, M Friedman
Oncology (Williston Park, N.Y.)|August 1, 1997
Clinical trials referral resourceB Cheson, J S Abrams, A P Nelson
Molecular Medicine (Cambridge, Mass.)|November 1, 1995
Administration of neutralizing antibodies to interleukin-6 (IL-6) reduces experimental autoimmune encephalomyelitis and is associated with elevated levels of IL-6 bioactivity in central nervous system and circulationK Gijbels, S Brocke, J S Abrams, et al.
Blood|April 1, 1991
Interleukin-5 is a human basophilopoietin: induction of histamine content and basophilic differentiation of HL-60 cells and of peripheral blood basophil-eosinophil progenitorsJ A Denburg, J E Silver, J S Abrams
The Journal of Trauma|July 1, 1976
Pulmonary function in patients with multiple trauma and associated severe head injuryJ S Abrams, R S Deane, J H Davis
Oncology (Williston Park, N.Y.)|December 1, 1993
Clinical trials referral resource. Metastatic breast cancerB D Cheson, P H Phillips, J S Abrams
Annals of Internal Medicine|October 1, 1996
High-dose chemotherapy for breast cancerW J Gradishar, M S Tallman, J S Abrams
Pageof 13